Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable (III)-13-1 (IGHVIII-13-1) is classified as a pseudogene within the immunoglobulin heavy chain variable region family. Pseudogenes are DNA sequences that closely resemble functional genes but are not translated into functional proteins due to disabling mutations, lack of regulatory elements, or incomplete transcripts[8][6][2]. IGHVIII-13-1 does not produce a functional immunoglobulin heavy chain variable region and therefore does not participate in immune response, antigen binding, or related biological activities. While functional immunoglobulin heavy variable genes play a central role in B cell-mediated immunity, IGHVIII-13-1 specifically is non-coding and biologically inert in terms of immune function[8][2][6]. If information is needed for a functional immunoglobulin heavy variable gene or a validated therapeutic antibody target, it is recommended to specify a protein-coding immunoglobulin heavy variable gene (such as IGHV1-3 or IGHV1-46)[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable (III)-13-1 (IGHVIII-13-1).